Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Obermayr, Eva ^a,d   Sanchez Cabo, Fatima ^b   Tea, Muy Kheng M ^a   Singer, Christian F ^a   Krainer, Michael ^a   Fischer, Michael B ^a   Sehouli, Jalid ^c   Reinthaller, Alexander ^a   Horvat, Reinhard ^a   Heinze, Georg ^a   Tong, Dan ^a   Zeillinger, Robert ^a,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Ludwig Boltzmann Cluster of Translational Oncology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; HUMAN MAMMOGLOBIN A; ONCOPROTEIN; PROTEIN CCNE2; PROTEIN DKFZP762E1312; PROTEIN MAL2; PROTEIN PPIC; PROTEIN SLC6A8; UNCLASSIFIED DRUG; CCNE2 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CYCLINE; DNA BINDING PROTEIN; EMP2 PROTEIN, HUMAN; MAL2 PROTEIN, HUMAN; MAML1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; NERVE PROTEIN; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORTER; PROTEOLIPID; SLC6A8 PROTEIN, HUMAN; TACSTD1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR ANTIGEN; TUMOR MARKER; VESICULAR TRANSPORT PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROFLUIDICS; MOLECULAR GENETICS; OVARY CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; UTERINE CERVIX CANCER; AUSTRIA; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; ENDOMETRIUM TUMOR; EVALUATION; FEMALE GENITAL TRACT TUMOR; GENETICS; GERMANY; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; OVARY TUMOR; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; TUMOR CELL LINE; TUMOR EMBOLISM; UTERINE CERVIX TUMOR;

ADULT; AGED; ANTIGENS, NEOPLASM; AUSTRIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CYCLINS; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENITAL NEOPLASMS, FEMALE; GERMANY; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOLIPIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VESICULAR TRANSPORT PROTEINS;

EID: 78649613643     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-666     Document Type: Article

References (33)

1. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. , http://www-dep.iarc.fr
2. Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aus Med J 1869, 14:146-149.
3. Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 2007, 253(2):180-204. 10.1016/j.canlet.2006.12.014, 17314005.
4. Smerage JB, Hayes DF. The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer 2006, 94(1):8-12. 10.1038/sj.bjc.6602871, 2361069, 16317435.
5. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 2006, 13(4):1033-1067. 10.1677/ERC-06-0001, 17158753.
6. Zieglschmid V, Hollmann C, Bocher O. Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci 2005, 42(2):155-196. 10.1080/10408360590913696, 15941083.
7. Marth C, Kisic J, Kaern J, Trope C, Fodstad O. Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis. Cancer 2002, 94(3):707-712. 10.1002/cncr.10250, 11857303.
8. Wimberger P, Heubner M, Otterbach F, Fehm T, Kimmig R, Kasimir-Bauer S. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer. Gynecol Oncol 2007, 107(2):331-338. 10.1016/j.ygyno.2007.07.073, 17764727.
9. Diddle AW, Sholes DM, Hollingsworth J, Kinlaw S. Cervical carcinoma; cancer cells in the circulating blood. Am J Obstet Gynecol 1959, 78:582-585.
10. Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Noguchi M, Nakanishi M, Kawai M. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001, 80(2):139-144. 10.1006/gyno.2000.6067, 11161851.
11. Ji XQ, Sato H, Tanaka H, Konishi Y, Fujimoto T, Takahashi O, Tanaka T. Real-time quantitative RT-PCR detection of disseminated endometrial tumor cells in peripheral blood and lymph nodes using the LightCycler System. Gynecol Oncol 2006, 100(2):355-360. 10.1016/j.ygyno.2005.08.041, 16203027.
12. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351(8):781-791. 10.1056/NEJMoa040766, 15317891.
13. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23(7):1420-1430. 10.1200/JCO.2005.08.140, 15735118.
14. Pachmann K, Camara O, Kavallaris A, Schneider U, Schunemann S, Hoffken K. Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring. Breast Cancer Res 2005, 7(6):R975-979. 10.1186/bcr1328, 1410761, 16280045.
15. Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, Dawood S, Reuben JM, Kau SW, Lara JM, et al. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 2007, 7(6):471-479. 10.3816/CBC.2007.n.004, 17386124.
16. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, Martens JW, Gratama JW, Sleijfer S, Foekens JA. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009, 101(1):61-66. 2639293, 19116383.
17. Medical devices; immunology and microbiology devices; classification of the immunomagnetic circulating cancer cell selection and enumeration system. Final rule. Fed Regist 2004, 69(91):26036-26038.
18. Zhong XY, Kaul S, Eichler A, Bastert G. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow. Arch Gynecol Obstet 1999, 263(1-2):2-6. 10.1007/s004040050251, 10728619.
19. Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Anticancer Res 2003, 23(2C):1883-1890.
20. Stathopoulou A, Angelopoulou K, Perraki M, Georgoulias V, Malamos N, Lianidou E. Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer. Clin Biochem 2001, 34(8):651-659. 10.1016/S0009-9120(01)00276-4, 11849626.
21. Roncella S, Ferro P, Bacigalupo B, Pronzato P, Tognoni A, Falco E, Gianquinto D, Ansaldo V, Dessanti P, Fais F, et al. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. J Exp Clin Cancer Res 2005, 24(2):265-271.
22. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
23. Ge YDS, Speed TP. Resampling-based multiple testing for microarray data analysis. Test 2003, 12:1-44.
24. Gleiss A, Sanchez-Cabo F, Perco P, Tong D, Heinze G. Adaptive trimmed t-statistics for identifying predominantly high expression in a microarray experiment. Stat Med
25. Klein CA, Seidl S, Petat-Dutter K, Offner S, Geigl JB, Schmidt-Kittler O, Wendler N, Passlick B, Huber RM, Schlimok G, et al. Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotechnol 2002, 20(4):387-392. 10.1038/nbt0402-387, 11923846.
26. Mikhitarian K, Martin RH, Ruppel MB, Gillanders WE, Hoda R, Schutte del H, Callahan K, Mitas M, Cole DJ. Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer 2008, 8:55. 10.1186/1471-2407-8-55, 2292197, 18289390.
27. Zeillinger R, Fabjani G. Method and kit for diagnosis of a cancerous disease, method for determining the reaction of a patient to the treatment for a cancerous disease, medicament for the prophylaxis or treatment of a cancerous disease. European Patent No. 1786929 2006,
28. Gervasoni A, Monasterio Munoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O. Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett 2008, 263(2):267-279. 10.1016/j.canlet.2008.01.003, 18262345.
29. Konigsberg R, Gneist M, Jahn-Kuch D, Pfeiler G, Hager G, Hudec M, Dittrich C, Zeillinger R. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods. Cancer Lett 293(1):117-123. 10.1016/j.canlet.2010.01.003, 20167419.
30. Lauper N, Beck AR, Cariou S, Richman L, Hofmann K, Reith W, Slingerland JM, Amati B. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 1998, 17(20):2637-2643. 10.1038/sj.onc.1202477, 9840927.
31. Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Janicke F, Pantel K. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 2005, 11(10):3678-3685. 10.1158/1078-0432.CCR-04-2469, 15897564.
32. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP. Genome screening by comparative genomic hybridization. Trends Genet 1997, 13(10):405-409. 10.1016/S0168-9525(97)01244-4, 9351342.
33. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998, 152(5):1107-1123. 1858578, 9588877.